Sartorius AG Stock

Equities

SRT3

DE0007165631

Advanced Medical Equipment & Technology

Market Closed - Xetra 11:35:22 2024-06-14 EDT 5-day change 1st Jan Change
245.7 EUR +1.87% Intraday chart for Sartorius AG +0.70% -26.26%

Financials

Sales 2024 * 3.55B 3.81B 5.23B Sales 2025 * 3.98B 4.26B 5.85B Capitalization 15.2B 16.28B 22.35B
Net income 2024 * 224M 240M 329M Net income 2025 * 353M 378M 519M EV / Sales 2024 * 5.42 x
Net Debt 2024 * 4.05B 4.34B 5.96B Net Debt 2025 * 3.82B 4.09B 5.61B EV / Sales 2025 * 4.78 x
P/E ratio 2024 *
67.7 x
P/E ratio 2025 *
46.7 x
Employees 14,614
Yield 2024 *
0.36%
Yield 2025 *
0.45%
Free-Float 35.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.87%
1 week+0.70%
Current month+1.74%
1 month-16.11%
3 months-32.16%
6 months-28.18%
Current year-26.26%
More quotes
1 week
240.30
Extreme 240.3
254.10
1 month
234.80
Extreme 234.8
276.50
Current year
234.80
Extreme 234.8
383.70
1 year
215.30
Extreme 215.3
383.70
3 years
215.30
Extreme 215.3
631.60
5 years
157.30
Extreme 157.3
631.60
10 years
19.00
Extreme 18.9975
631.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 99-04-30
Chief Tech/Sci/R&D Officer 59 94-12-31
Chief Operating Officer 67 00-12-31
Members of the board TitleAgeSince
Director/Board Member 69 19-12-31
Director/Board Member 75 11-11-28
Director/Board Member 58 17-04-05
More insiders
Date Price Change Volume
24-06-14 245.7 +1.87% 112,242
24-06-13 241.2 -1.59% 79,384
24-06-12 245.1 -1.76% 86,446
24-06-11 249.5 +0.40% 54,615
24-06-10 248.5 +1.84% 52,975

Delayed Quote Xetra, June 14, 2024 at 11:35 am

More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
245.7 EUR
Average target price
318.6 EUR
Spread / Average Target
+29.68%
Consensus